|
|
|
Volumn 22, Issue 142, 2013, Pages 229-231
|
|
Ivacaftor. Uncertain harm-benefit balance.
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOPHENOL DERIVATIVE;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
IVACAFTOR;
N-(2,4-DI-TERT-BUTYL-5-HYDROXYPHENYL)-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXAMIDE;
QUINOLONE DERIVATIVE;
ARTICLE;
BODY WEIGHT;
CYSTIC FIBROSIS;
DRUG EFFECT;
DRUG INTERACTION;
FORCED EXPIRATORY VOLUME;
HUMAN;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
UNCERTAINTY;
DRUG EFFECTS;
AMINOPHENOLS;
BODY WEIGHT;
CYSTIC FIBROSIS;
CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR;
DRUG INTERACTIONS;
FORCED EXPIRATORY VOLUME;
HUMANS;
QUINOLONES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
UNCERTAINTY;
|
|
EID: 84892412593
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|